We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Human Selenoprotein P Concentration With Glucose Tolerance Status

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: December 13, 2010
Last Update Posted: December 13, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Korea University
Recently, seslenium(Se) has known as important regulator in metabolic status, lipid profile, atherosclerosis progression. SEPP1(selenoprotein P1)is a secreted protein from mainly liver. This protein is used as an index of selenium nutritional status. The association between the concentration of SEPP1(selenoprotein P1) in normal glucose tolerance,impaired glucose tolerance, type 2 diabetes is still a matter of debate. This cross sectional study will evaluate whether glucose status is matter in SEPP1 level.

SEPP1 Levels in Differnet Glucose Tolerance Status

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Human Selenoprotein P Concentration With Glucose Tolerance Status

Further study details as provided by Korea University:

Normal, IGT, T2DM


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Total 180 patients Normal 60-IGT 60-T2DM 60

Inclusion Criteria:

  • 20-80 years old
  • Not severe medical condition

Exclusion Criteria:

  • metformin, insulin using type 2 diabetes
  Contacts and Locations
No Contacts or Locations Provided
  More Information

ClinicalTrials.gov Identifier: NCT01258426     History of Changes
Other Study ID Numbers: SEPP1(DM)
First Submitted: December 10, 2010
First Posted: December 13, 2010
Last Update Posted: December 13, 2010
Last Verified: December 2010